Pharma Manufacturing: Meeting Annex I with Precision Machining for Safer Sterile Drug Production

Pharmaceutical manufacturers are under increasing pressure to deliver sterile, high-quality medicines in smaller batches and faster cycles. As pharma manufacturing evolves, regulatory demands have intensified, especially following the 2023 revision of EU GMP Annex I, which places new emphasis on contamination control strategies, improved traceability, and minimizing human intervention throughout production. According to American Pharmaceutical Review, the updated guidelines specifically call for technologies that reduce human involvement and support robust contamination control. This requires manufacturers to rethink how precision machining and mechanical component design support advanced containment.

So how can manufacturers ensure safe, efficient, and scalable filling operations, especially when the stakes are patient lives?

On this episode of Exceeding Your Benchmark by Benchmark Products, host Michelle Dawn Mooney sits down with Corinna Politi , Head of Export Sales at MPA Technical Devices. They explore how MPA’s precision machining and customizable dosing components are enabling safer, more efficient sterile drug manufacturing in line with evolving global regulations.

Key Highlights from the Episode:

• Precision That Protects: MPA designs and manufactures critical components like dosing pumps and filling needles that directly contact pharmaceutical products, demanding ultra-high accuracy, sterile-friendly materials, and clean, smooth finishes to reduce contamination risk.
• Compliance Through Innovation: In response to Annex I revisions, MPA uses diamond-like carbon (DLC) coatings to replace chromium, reducing particle release risks and enhancing sterilization outcomes. A customer portal and QR-coded parts improve traceability.
• Future-Ready Customization: MPA emphasizes product customization for advanced therapies and small-batch production, offering everything from bespoke needle tips to single-use setups, while expanding support upstream and downstream in the filling line.

Corinna Politi is Head of Export Sales at MPA Technical Devices, where she leads international strategy for high-precision pharmaceutical components. She brings over a decade of experience in certification management, technical documentation, and export operations, with proven expertise in regulatory compliance, customer service, and multilingual communication. Her background spans quality assurance, sales coordination, and process optimization within the life sciences and mechanical engineering sectors.